跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Clavomex
Approved
STANDARD
Clavomex
J.M. Tolmann Laboratories, Inc
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
03bd082c92f98d30
Company
J.M. Tolmann Laboratories, Inc
Type
Standard
Approval Details
Approval Id
03bd082c92f98d30
Drug Approval Philippines Name
Clavomex
Product Name
Clavomex
Registration Number
DRP-12192-02
Brand Name
Clavomex
Generic Name
Co-Amoxiclav
Dosage Form
Powder for Oral Suspension
Dosage Strength
457 mg/5 mL
Manufacturer
J.M. Tolmann Laboratories, Inc
Distributor
CHMI Pharma, Inc
Issuance Date
28 March 2024
Expiry Date
02 September 2027
Pharmacologic Category
Antibacterial (Penicillin)s
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
03bd082c92f98d30
Type
Standard
Back to Philippines FDA Approvals
Clavomex - Philippines FDA Drug Approval Details